ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,542,000 | -4.8% | 21,665 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,619,000 | +73.0% | 21,665 | +63.9% | 0.00% | 0.0% |
| Q4 2018 | $936,000 | -14.1% | 13,215 | +3.6% | 0.00% | 0.0% |
| Q3 2018 | $1,090,000 | +268.2% | 12,752 | +398.5% | 0.00% | – |
| Q2 2018 | $296,000 | +23.8% | 2,558 | -57.6% | 0.00% | – |
| Q3 2014 | $239,000 | -88.1% | 6,030 | -87.1% | 0.00% | -100.0% |
| Q2 2014 | $2,008,000 | -1.1% | 46,615 | -8.2% | 0.00% | +50.0% |
| Q1 2014 | $2,030,000 | – | 50,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |